GIM
Grassi Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
2,379
-50
| -2% | -$6.33K | 0.02% | 112 |
|
|
2025
Q1 | $311K | Sell |
2,429
-2,830
| -54% | -$362K | 0.03% | 107 |
|
|
2024
Q4 | $695K | Sell |
5,259
-1,000
| -16% | -$132K | 0.06% | 85 |
|
|
2024
Q3 | $911K | Sell |
6,259
-450
| -7% | -$65.5K | 0.08% | 79 |
|
|
2024
Q2 | $921K | Sell |
6,709
-4,450
| -40% | -$611K | 0.08% | 75 |
|
|
2024
Q1 | $1.53M | Buy |
11,159
+359
| +3% | +$49.3K | 0.14% | 63 |
|
|
2023
Q4 | $1.47M | Sell |
10,800
-125
| -1% | -$17K | 0.15% | 63 |
|
|
2023
Q3 | $1.34M | Sell |
10,925
-950
| -8% | -$116K | 0.15% | 68 |
|
|
2023
Q2 | $1.51M | Sell |
11,875
-100
| -0.8% | -$12.7K | 0.17% | 68 |
|
|
2023
Q1 | $1.55M | Sell |
11,975
-35
| -0.3% | -$4.52K | 0.19% | 69 |
|
|
2022
Q4 | $1.58M | Sell |
12,010
-2,300
| -16% | -$302K | 0.21% | 70 |
|
|
2022
Q3 | $1.67M | Sell |
14,310
-375
| -3% | -$43.9K | 0.24% | 71 |
|
|
2022
Q2 | $1.73M | Sell |
14,685
-1,205
| -8% | -$142K | 0.23% | 73 |
|
|
2022
Q1 | $2.07M | Buy |
15,890
+400
| +3% | +$52.1K | 0.22% | 73 |
|
|
2021
Q4 | $2.36M | Buy |
15,490
+475
| +3% | +$72.5K | 0.24% | 74 |
|
|
2021
Q3 | $2.43M | Buy |
15,015
+110
| +0.7% | +$17.8K | 0.27% | 68 |
|
|
2021
Q2 | $2.44M | Buy |
14,905
+125
| +0.8% | +$20.5K | 0.26% | 67 |
|
|
2021
Q1 | $2.23M | Buy |
14,780
+175
| +1% | +$26.3K | 0.25% | 67 |
|
|
2020
Q4 | $2.21M | Buy |
14,605
+1,925
| +15% | +$292K | 0.28% | 68 |
|
|
2020
Q3 | $1.72M | Buy |
+12,680
| New | +$1.72M | 0.24% | 67 |
|